Article info

Download PDFPDF
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group

Authors

  1. Address correspondence and reprint requests to: Dr Amit Oza, MD, Department of Medical Oncology, Princess Margaret Hospital, 610 University Avenue, Suite, Toronto, Ontario M5G 2M9, Canada. Email: amit.oza{at}uhn.on.ca

Citation

Ma BBY, Oza A, Eisenhauer E, et al
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group

Publication history

  • First published June 1, 2004.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.